QuickView for garcinol (compound)

1. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (3 of 4)
2. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (2 of 4)
3. L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
4. L1000 CMAP - Neural progenitor NPC.CAS9 cells treated with small molecule perturbagens
5. L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)

1. Garcinol and its analogues: Synthesis, cytotoxic activity and mechanistic investigation.
2. Chemometric assisted natural DES based VA-DLLME-LC-MS/MS method for the quantitative determination o…
3. Binding mechanism of anacardic acid, carnosol and garcinol with PCAF: A comprehensive study using mo…
4. Structural Revision of Guttiferone F and 30-epi-Cambogin.
5. Garcinol and Anacardic Acid, Natural Inhibitors of Histone Acetyltransferases, Inhibit Rhabdomyosarc…

There were no clinical trials for garcinol